Journal of Oncology Pharmacy Practice

Article	Citations
Temporal effect of imatinib adherence on time to remission in chronic myeloid leukemia patients	24
Mercaptopurine induced myelosuppression in a child with a NUDT15 rs116855232 homozygous variant	19
Cellular therapy site-preparedness: Inpatient pharmacy implementation at a large academic medical center	17
Evaluation of hepatotoxicity due to conditioning regimens in beta thalassemia major and aplastic anemia patients undergoing bone marrow transplantation	17
Identifying health disparities in lenalidomide access	16
Initial real-world experience with ribociclib in advanced breast cancer	15
Exploring the potential relationship between antineoplastic agents and their association with stomatitis and oral candidiasis in cancer patients	15
Immunosuppressant adherence in adult outpatient hematopoietic cell transplant recipients	14
Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancer	14
Corrigendum to A review on radiation induced nausea and vomiting: “Current management strategies and prominence of radio sensitizers”	13
Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies	12
Clinical characteristics and risk factors for oxaliplatin hypersensitivity reactions in patients with colorectal cancer	12
A room of errors simulation to improve pharmacy operators’ knowledge of cytotoxic drug production	12
Polypharmacy and drug-drug interactions in metastatic breast cancer patients receiving cyclin-dependent kinase (CDK) 4/6 inhibitors	12
Comprehensive pharmacological geriatric assessment compared to usual care in an older adult with cancer in the absence of polypharmacy	12
Rituximab-induced severe acute thrombocytopenia in a patient with splenic marginal zone lymphoma	11
Assessing the impact of aprepitant on response to dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP)	11
Nivolumab-induced immune-related neutropenia in a renal cell carcinoma patient	11
Trend analysis of pharmacist involvement in cancer care in Japan from 2015 to 2020: A nationwide survey study on hospital pharmacy practice	11
Premedication strategy in cetuximab rechallenge after Grade 2 hypersensitivity reactions	10
CAPhO Conference 2024 Abstract Book	10
Assessment of chemical contamination by cancer drugs during use of the RIVA TM compounding robot: A pilot study	10
Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 124 centers	10
Recurrent and atypical immune checkpoint inhibitor-induced pneumonitis	10
Evaluation of proteinuria monitoring practice patterns and treatment implications in patients with cancer receiving bevacizumab products	10

Post COVID availability of oncology drugs – Is this the new normal on both sides of the Atlantic?	10
Safety and efficacy of Vitamin C, Vitamin E, and selenium supplementation in the oncology setting: A systematic review	10
Melphalan on day -1 versus day -2 in patients with plasma cell disorders undergoing autologous stem cell transplant	10
Evaluating aggressiveness of end-of-life care in patients with advanced cancer: A retrospective single-center analysis	9
Impact of institutional interventions on the rate of paclitaxel hypersensitivity reactions	9
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant	9
Gemcitabine-associated DRESS syndrome: A case report	9
Clinical uses and safety concerns of tyrosine kinase inhibitors with a focus on novel drugs: A narrative review	8
Cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer	8
Attitude of healthcare professionals toward the use of complementary and alternative medication during anti-cancer therapy	8
Use of two general-purpose scales to assess clinical pharmacy activities in a cell transplantation unit	8
Antiandrogen therapies: Management of drug interactions with anticoagulation	8
Use of long-term corticosteroids in patients treated with CAR T-cell therapy	8
Revitalizing oncology medications access in Saudi Arabia: Current challenges and recommendations by the Saudi Oncology Pharmacy Assembly	8
Hypokalemia, hypomagnesemia, and hyponatremia are associated with acute kidney injury in patients treated with cisplatin	8
Estimation of financial burden of breast cancer and its effect on quality of life	8
Economic impact of lung cancer clinical trials: Assessing cost savings in medication and testing	8
Efficacy and safety of bone management agents administered at 12 weeks vs. 4 weeks in patients with bone metastases: A systematic review	8
Acute pancreatitis associated with pembrolizumab-induced hypertriglyceridemia	8
Immunotherapy “stop and go” and early discontinuation: A viable option in limited resources setting	8
CAPhO Conference 2026 Abstract Book	8
Navigating biosimilar transitions in IV rituximab therapy: Efficacy and safety insights from a real-world switching study	8
Nivolumab–ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment	7
Oral oncolytic monitoring pilot with patient-reported outcomes and adherence assessments	7
The inpatient oncology pharmacist experience in the era of temporary oncologists	7
Safety and tolerability of lenalidomide maintenance dosing in patients with multiple myeloma post-autologous stem cell transplant	7
Antimicrobial prophylaxis in pediatric patients with leukemia: Reducing incidence of febrile neutropenia episodes and bloodborne infections	7
Continuous versus intermittent tacrolimus for graft-versus-host disease prophylaxis in pediatric hematopoietic stem cell transplantation patients (Tic Tac)	7
Perception, knowledge, and handling practice regarding the risk of exposure to antineoplastic drugs in oncology day hospitalization units and compounding unit staff	7
Retrospective cross-sectional study of drug utilisation and expenditure of anticancer drugs at zonal referral hospital central, Tanzania	7
Rapid drug desensitization to taxanes: a descriptive study from Turkey	7
Inpatient utilization of immune checkpoint inhibitors and clinical outcomes	7
Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia	7
Risk-based analytical quality control of chemotherapy preparations: A simulation and FMECA approach	7
Risk assessment of pneumatic tube systems for in-hospital transportation of biotherapeutics	7
Medical marijuana in the treatment of cancer-associated symptoms	7
Successful dasatinib therapy in newly diagnosed chronic myeloid leukemia in the setting of short bowel syndrome	7
Pembrolizumab induced type 1 diabetes mellitus in a patient with metastatic melanoma and literature review on steroids as a treatment option	7
Descriptive analysis of the efficacity of R-GEMOX /R-IE/R-CEPP in patients with relapsed/refractory (R/R) transplant-ineligible diffuse large B-cell lymphoma (DLBCL)	6
Pharmacist-led anticoagulation care in cancer: Associations with bleeding and VTE recurrence	6
Activated carbon adsorption sheets suppress volatilization of anticancer drugs excreted in urine, preventing environmental contamination and human exposure	6
Hepatic sinusoidal congestion associated with inotuzumab therapy in patients with B-cell acute lymphoblastic leukemia, a proposal for a new clinical entity: Calicheamicin syndrome	6
Feasibility study of an innovative simulation-based learning program in hospital oncology pharmacy: A pilot project in a faculty of pharmacy	6
Characteristics of the clinical pharmacist interventions at the National Center for Cancer Care and Research Hospital in Qatar	6
Utilization of cefepime therapeutic drug monitoring in febrile neutropenia patients with hematologic malignancies	6
Real-world effectiveness of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and advanced melanoma at BC Cancer	6
Safety and tolerability of adjuvant combination treatments following KEYNOTE-522 for early-stage or locally advanced breast cancer with residual disease	6
Pembrolizumab related perforated appendicitis	6
Innovation in hospital pharmacy: Modeling the installation of automated dispensing systems based on an oncology hospital experience transfer	6
Usefulness of hydrocortisone prophylaxis for oxaliplatin-induced hypersensitivity reactions: A retrospective study	6

Erratum to Evaluation of antibiotic appropriateness at an outpatient oncology centre	6
Hypersensitivity reaction to Abiraterone, successful desensitization protocol in prostate cancer patient	6
Capecitabine-related neurotoxicity presenting with agraphia	6
Intravenous route for folate supplementation in a patient with celiac disease treated by pemetrexed-based chemotherapy for non-small-cell lung cancer	6
Evaluation of oral silymarin formulation efficacy in prevention of doxorubicin induced hepatotoxicity in patients with non-metastatic breast cancer	6
Genetic variants found in paediatric oncology patients with severe chemotherapy-induced toxicity: A case series	6
Retrospective study on the efficacy and tolerability of dose modification of PD-1 and PD-L1 inhibitors in hospital-system community outpatient cancer clinics	6
Pharmacist's role in the management of drug–drug interactions caused by nirmatrelvir/ritonavir in COVID-19 oncohematology patients	6
Oncology pharmacy practice in Nepal: Integration, challenges, and policy directions	5
Misalignment between patient preferences and clinician expectations: Do press releases make clinicians impatient to the detriment of patients?	5
A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review	5
Immune checkpoint inhibition in advanced colorectal cancer with inherited and acquired microsatellite instability: Current state and future directions	5
Posterior reversible encephalopathy syndrome triggered by FLOT (5-fluorouracil, oxaliplatin, docetaxel, and calcium levofolinate) chemotherapy and thrombocytopenia (docetaxel and cisplatin) chemothera	5
Anti-cancer drug waste disposal practices and wastewater management in hospitals: A Lebanese survey	5
Adverse drug reactions associated with doxorubicin and epirubicin: A descriptive analysis from VigiBase	5
Investigating effective methods of clinical pharmacy training on oncology for community pharmacists: An observational study	5
Predictors of fluid overload in allogeneic hematopoietic cell transplant patients receiving post-transplant cyclophosphamide	5
Comparison of first and third generation EGFR-TKIs for the treatment of advanced non-small cell lung cancer: A real-world study	5
Examining clinical pharmacist interventions and identifying opioid medication-related issues in patients with cancer	5
Time-saving impact of two generation model chemotherapy compounding robots on pharmacists’ daily workflow: A long-term evaluation	5
The role of the pharmacist in the hospital discharge of cancer patients: an integrative review	5
Single center evaluation on the use of conditionally ordered low molecular weight heparins in malignant hematology patients with venous thromboembolism	5
Rasburicase dose optimization for tumor lysis syndrome management in a network of community oncology practices	5
Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexate	5
Safety of alisertib in the treatment of solid and hematological cancers: A systematic review and meta-analysis of randomized controlled trials	5
Oral anticancer medicine interventions: A cross-sectional study in French community pharmacies	5
An assessment of the prevalence of drug therapy problems and its associated factors among ovarian cancer patients at Kenyatta National Hospital	5
Evaluation of potential cost savings through chemotherapy and biotherapy dose-rounding at a pediatric institution	5
Automated chemotherapy compounding: Process optimization for the preparation of admixture containing high-dose of cyclophosphamide	5
Cytotoxic surface contamination in hospitals: Current practices, challenges and perspectives	5
Assessment of chemotherapy dosing and regimen optimization in geriatric oncology patients diagnosed with solid organ malignancies	5
Evaluating patients on immune checkpoint inhibitors for cardiac adverse events: The EPICC study	5
Efficacy and safety of adjuvant capecitabine and pembrolizumab in early-stage triple-negative breast cancer after standard neo-/adjuvant chemotherapy: A meta-analysis of phase III studies	5
Acute infusion-related reactions in pediatric patients receiving etoposide at a tertiary cancer center	5
Sacituzumab govitecan in breast cancer patients – an evaluation of progression-free survival, overall survival, and hypersensitivity reactions in real-world patients	5
Identifying risk factors of dose reduction or treatment discontinuation due to fatigue or gastrointestinal symptoms in patients receiving lenvatinib treatment for hepatocellular carcinoma	5
Medication errors in an oncology inpatient setting in India—Audit by clinical pharmacists	5
Effectiveness of antiemetic in reducing chemotherapy-induced nausea and vomiting in adult patients; An oncology center experience	5
Laryngopharyngeal dysesthesia as a possible clinical manifestation of a cytokine release reaction due to oxaliplatin	4
Evaluation of real-world versus clinical trial outcomes of tyrosine kinase inhibitor therapy for chronic myeloid leukemia	4
Hypersensitivity reactions to chemotherapy and biologics: Outcomes and safety of 927 desensitization in Mexico	4
Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune disease: An integrative review	4
Cabozantinib-induced heart failure	4
Factors associated with potentially inappropriate medications in elderly with multiple myeloma	4
Real-world experience of abemaciclib for adjuvant and metastatic breast cancer	4
Corrigendum to Audit on Oral Systemic Anti-Cancer Therapies (SACT) Adherence Using the Morisky Medication Adherence Scale (MMAS): Implications for Pharmacy Counselling	4
Comment on ‘risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy’	4
Safety and oncological effectiveness after desensitization in patients with previous hypersensitivity reactions to chemotherapy	4
Central line-associated Rhizobium radiobacter bloodstream infection in two allogeneic hematopoietic cell transplant recipients	4
Improving palbociclib adherence among women with metastatic breast cancer using a CONnected CUstomized Treatment Platform: A pilot study	4
Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis	4
Exploring the toxicity and clinical outcomes of doxorubicin, cyclophosphamide, and taxane-based chemotherapies in women with breast cancer in Bangladesh	4
Tafasitamab and lenalidomide for relapsed/refractory diffuse large B-cell lymphoma in a patient on chronic intermittent hemodialysis	4
Managing suspected myasthenia gravis and myositis induced by pembrolizumab in a Jehovah's Witness sarcoma patient	4
Chronic cannabis use in breast cancer survivors: A questionnaire study of Israeli patients	4
Meperidine compared to morphine for rigors associated with monoclonal antibody-related infusion reactions	4
Efficacy of pegfilgrastim in preventing febrile neutropenia during DCF chemotherapy for esophageal cancer: A systematic review and meta-analysis	4
Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital	4
Implementation of pharmaceutical care service to elderly cancer patients in a tertiary care hospital in South India	4
Drug induced lupus associated with Trastuzumab emtansine in a patient with metastatic breast cancer	4
Safe handling of hazardous drugs	4
Perceptions and prevalence of marijuana use among cancer patients managed at an outpatient department in Zimbabwe: A brief report	4
The effect of examining somatic alterations with NGS in patients with solid tumors, on patient management: A single-center experience in Turkey	4
Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer	4
Pharmacy practitioners’ adherence to safe-handling practices of chemotherapeutic drugs: A cross-sectional study in Saudi Arabia	4
Overcoming language barriers to enhance pharmaceutical care: Design and validation of a pictogram-based tool for cancer patients	4
Manual versus automated chemotherapy preparation: A retrospective pharmaco-economic analysis	4
Concern regarding “A novel decision tree for performing risk assessments of biologics in a health-system setting”	4
A prospective analysis of efficacy of dexamethasone-sparing antiemetic regimens in high and moderate emetogenic chemotherapy	4
Nearly complete hair re-pigmentation in an older patient treated with hydroxyurea for essential thrombocytosis	4
Safety evaluation of outpatient ifosfamide regimens in adult sarcoma patients	4
The effect of Bevacizumab treatment on the incidence of hypertension in patients with ovarian cancer: a systematic review and meta-analysis	4
Residual contamination in antineoplastic drug packaging	4
Midostaurin-Associated acute pancreatitis	4
Imatinib mesylate-induced acute hepatotoxicity	4
Patterns and predictors of antidepressant prescribing among adults with cancer and depression in ambulatory care settings in the United States	4
Oncology stewardship: A narrative review of principles and practices	4
Evaluating the efficacy of a premedication regimen including high-dose cetirizine in reduction of hypersensitivity reactions to paclitaxel: A retrospective cohort study	4
ISOPP International Symposium 2026 Abstracts	4
Therapeutic potential of phytoconstituents in oncocosmetics: A systematic review on radiodermatitis management	4

Therapeutic outcomes of patients with acute erythroid leukemia treated with hypomethylating agents	4
A case of palmar-plantar erythrodysesthesia in a lung cancer patient receiving atezolizumab maintenance	4
Carboplatin dosing in obese patients	4
Workflow evaluation of environmental contamination with hazardous drugs during compounding and administration in an UK hospital	4
Knowledge, attitudes, and practices among oncology pharmacists on cytotoxic drug reconstitution in Sri Lanka: A cross-sectional study	4
Nivolumab-induced pneumonitis and cardiopathy in a patient with relapsed Hodgkin's lymphoma	4
Bilateral epithelial keratopathy and punctate keratitis due to ribociclib	4
Factors affecting medication adherence in patients using oral chemotherapy: A descriptive study	4
Effects of scalp lotion containing alpha lipoic acid derivatives for chemotherapy-induced alopecia in patients with gastrointestinal cancer: A prospective cohort study	3
Docetaxel-induced severe neuropathy, a case of breast cancer with GTSP1 polymorphism	3
Assessment of adverse drug reactions among acute myeloid leukaemia patients at Kenyatta National Hospital	3
Acquired angioedema late in the course of nivolumab treatment	3
Pirtobrutinib: A novel non-covalent BTK inhibitor for the treatment of adults with relapsed/refractory mantle cell lymphoma	3
Anti-cancer medicine shortages in an oncology tertiary hospital of Pakistan: A five-year retrospective study	3
Risk assessment of personnel exposure in a central cytotoxic preparation unit using the FMECA method	3
One patient, one order? analyzing prescription volume in oncology opioid stewardship	3
Oncology stewardship practice in the United States: A Hematology/Oncology Pharmacy Association national survey	3
A case of castration-resistant metastatic prostate cancer who continued treatment with enzalutamide after epileptic seizure	3
Enhancing access to expensive oncology medications in Pakistan: The critical role of pharmaceutical patient assistance programs in oncology care	3
Antithrombotic and hemostatic stewardship: Evaluation of romiplostim for treatment of thrombocytopenia at a large academic medical center	3
Implementation of a pharmacist-guided pharmacogenomics dosing service at a rural NCI-designated comprehensive cancer center	3
Artificial intelligence-based muscle analysis risk assessment of treatment-related toxicity in metastatic colorectal cancer	3
Pharmacist interventions in optimising opioid medication therapy in pain management for palliative care patients: A systematic review	3
Development of an African paediatric oncology pharmacy curriculum: A SIOP Africa 2024 pharmacy workshop output	3
An assessment of exposed syringe inner walls as a route of exposure from hazardous drugs	3
Rechallenges without desensitization following platinum-based chemotherapy reactions	3
Impact of telephone follow-up on hepatocellular carcinoma patients receiving oral chemotherapy from an ambulatory-care setting	3
Pharmacy considerations: Use of anti-CD38 monoclonal antibodies in relapsed and/or refractory multiple myeloma	3
Overcome Daratumumab’ severe reaction with desensitization in relapsed multiple myeloma	3
Implementation of a comprehensive medication management service for radioiodine therapy patients at an oncology hospital in Rio de Janeiro	3
Pacritinib and concurrent azole antifungal therapy is deliverable in patients with hematologic malignancies	3
Mild forms of thrombotic microangiopathy in patients with advanced pancreatic cancer receiving gemcitabine and nab-paclitaxel	3
A simple and inexpensive method to monitor and minimize exposure from manipulation of cytotoxic drugs	3
A pilot study to determine the feasibility and safety of pharmacist and nurse driven management of venetoclax ramp-up in patients with chronic lymphocytic leukemia	3
Cost analysis of closed-system transfer devices in bortezomib handling in a Brazilian cancer center	3
Investigation of the frequency of bortezomib neuropathy in patients with multiple myeloma diagnosis with normal and abnormal genetic characteristics	3
Breast self-examination through health education from community pharmacy	3
Vinorelbine-related tetraplegia due to severe peripheral neuropathy	3
Effect of direct oral anticoagulants compared to enoxaparin on objective response to immune checkpoint inhibitors in patients with lung cancer	3
Reduced initial Pazopanib dosing strategy for recurrent, advanced, or metastatic sarcoma: A single center experience	3
Selinexor for the treatment of patients with relapsed or refractory multiple myeloma	3
Predictive risk factors associated with cancer therapy-related cardiac dysfunction: A retrospective cohort study	3
Safe administration of temozolomide in end-stage renal disease patients	3
Rethinking centralised oncology pharmacy practice in the era of flat-dose immunotherapy, subcutaneous formulations and visit-administration day separation: A conceptual analysis and reform proposal	3
Diagnosis and management of immune checkpoint inhibitor-associated adrenal insufficiency: A single-institution experience	3
Safety outcomes of teclistamab accelerated dose escalation	3
Cycle-dependent eosinophilia due to adjuvant nivolumab for malignant melanoma	3
Toxic hepatitis in metastatic breast cancer patient using ribociclib and denosumab	3
Correlation between lymphocyte counts and PD-L1 immune-related adverse events	3
Impact of healthcare providers’ training (ISOPP-OPAB) on biosimilars use for cancer care at a university hospital in Nigeria	3
Tamoxifen induced maculopathy presenting like macular telangiectasia type 2 in a patient with breast cancer	3
Redispensing of expensive oral anticancer medicines: A practical application	3
A critical appraisal of South African oncology pharmacy standards: A comparison with international best practice standards	3
Oncology pharmacy staffing survey across practice settings in the United States	3
New-onset persistent hyperglycemia with initiation of brentuximab treatment	3
Assessment of chemotherapy-related educational needs of colorectal cancer patients	3
Exploring an enhanced role of the pharmacy technician in cancer services within the uk independent sector	3
Evaluating the impact of a pharmacist-led venetoclax ramp-up clinic for chronic lymphocytic leukemia patients: A retrospective chart review	3
Corrigendum to Role of sacituzumab govitecan in solid tumors	3
Assessment of potential drug–drug interactions in hospitalized cancer patients	3
Impact of an oncology pharmacist–led, well-developed and validated chemotherapy order template on quality of life in breast cancer patients: A randomized controlled trial	3
A study to quantify knowledge obtained during the British Oncology Pharmacy Association (BOPA) Introduction to Oncology (ITO) Course	3
Incidence of invasive fungal infections in patients with chronic lymphocytic leukemia receiving ibrutinib within the veteran’s healthcare administration	3
Increased alanine aminotransferase level as a predictive marker of hand-foot syndrome in patients receiving capecitabine: A retrospective cohort study	3
Nutrition support pharmacy practices in hospitalized cancer patients admitted to bone marrow transplant units: A 3-year retrospective analysis of clinical nutrition support pharmacists’ interventions	3
Advancements in the use of nanopharmaceuticals for cancer treatment	3
Oncology stewardship: Role of the pharmacists for contribution in low and middle-income countries	3
Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring	3
A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions	3
Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma	3
Real world comparison of filgrastim to filgrastim-sndz in patients with chemotherapy-induced neutropenia	3
CyFRASS-TR: A practical clinical predictive model for acute irinotecan-induced toxicity to enhance patient safety in solid tumor management	3
Vomiting of oral medications by pediatric patients: Survey of medication re-dosing practices in pediatric oncology and stem cell transplant centers	3
Optimizing intermittent dosing of oral small molecule inhibitors	3
A comprehensive study of adverse effects of chemotherapy on female breast cancer patients in NORI Cancer Hospital, Islamabad in a developing country	3
Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer	3
A fully validated HPLC-UV detection method associated with color variation control for the evaluation of the long term stability of calcium levofolinate solutions in polyolefin infusion bags and in po	3
Cytomegalovirus viremia and hepatitis B reactivation in patient with RET fusion-positive non-small cell lung cancer treated with pralsetinib	3
Hypercalcemia associated with interaction between all trans retinoic acid and fluconazole in an acute promyelocytic leukemia and acquired hypoparathyroidism case	3
Evaluating the clinical benefit of pembrolizumab as a first-line agent in advanced solid tumors: A comprehensive review	3
Implementation of Partnered Pharmacist Medication Charting in haematology and oncology inpatients	3
Drug extravasation with Enfortumab vedotin	3
Optimizing antimicrobial prophylaxis strategies in acute leukemia patients: Assessing the efficacy of fluconazole	3
The relationship between immune-related adverse events during ipilimumab monotherapy and survival outcomes among melanoma patients: A systematic review	3
Contamination on the external surface of hazardous drug vials wrapped in Vial Protect Pack shrink tack labels	3
Comparative pooled analysis of targeted therapies, or immunotherapy plus chemotherapies versus conventional platinum-based therapies or single-agent immunotherapies in recurrent or metastatic head and	3
Impact of obesity on doxorubicin pharmacokinetics in women with breast cancer	3
Perception, knowledge, practices and training regarding the risk of exposure to antineoplastic drugs in three French compounding units	3
Chemotherapy regimen for recurrent uterine leiomyosarcoma	2
Administration of teclistamab in four patients with multiple myeloma requiring hemodialysis	2
Colonic mucosal diffuse congestion associated with Osimertinib	2
Pembrolizumab-induced agranulocytosis	2
Medication-related problems among patients with cervical cancers at oncology centers of University of Gondar comprehensive specialized hospital: A hospital-based retrospective study	2
Monoclonal-induced cardiotoxicity in patients with non-Hodgkin's lymphoma and breast cancer: A retrospective study in an oncology clinic	2
Withdrawal pain following patients discontinuing Trk inhibitors	2